Kyungdong Pharm경동제약
011040 · KOSDAQ · ₩011040 · 경동제약
- Market cap
- ₩153B
- Enterprise value
- ₩165B
- P/E
- 8.6×
- P/B
- 0.7×
- Dividend yield
- 6.0%
- ROE
- 7.7%
- Net margin
- 8.9%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−20.8% from the high
₩4,700Today: ₩4,905 – ₩4,965₩6,270
Returns
- 1W−1.1%
- 1M−1.1%
- 3M+1.0%
- 6M−11.3%
- YTD−15.0%
- 1Y−14.7%
- Volume today
- 17,476
- 0.7× the 20-day average
- Traded today
- ₩86M
- Listed shares
- 30,768,766
- EPS (12 months)
- ₩580
- Earnings yield 11.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
- MomentumFlat-1.1% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Kyungdong Pharm stock overview
Kyungdong Pharm (경동제약, KRX: 011040) is listed on KOSDAQ, in the Biotech & Pharma sector. The company, established in 1976, manufactures and sells pharmaceuticals and operates through three segments: pharmaceuticals, leasing, and other businesses. Its shares closed at ₩4,965 on Oct 27, 2026, up 1.22% on the day, giving it a market value of ₩153B.
Key facts
- Market cap
- ₩153B
- Sector
- Biotech & Pharma
- Latest price change
- +1.22%
- As of
- Oct 27, 2026
- Main business
- The company, established in 1976, manufactures and sells pharmaceuticals and operates through three segments: pharmaceuticals, leasing, and other businesses.
Quick answers about Kyungdong Pharm
- What does Kyungdong Pharm do?
- The company, established in 1976, manufactures and sells pharmaceuticals and operates through three segments: pharmaceuticals, leasing, and other businesses. Its pharmaceutical segment accounts for about 95% of sales, with its main products including Duoloban tablets for circulatory system treatment and Alfotin soft capsules as a key merchandise item. Sales are made domestically to hospitals, clinics, pharmacies, and pharmaceutical companies, mainly through direct sales or drug wholesalers, and exports are handled through pharmaceutical trading companies, with exports making up roughly 1% of sales.
- What is the market cap of Kyungdong Pharm?
- The market capitalisation of Kyungdong Pharm was ₩153B at the close on Oct 27, 2026.
- Who are the largest shareholders of Kyungdong Pharm?
- According to the latest official filings, the largest reported holders are Ryu Gi-seong (45.75%, as of Aug 31, 2026); Ryu Deok-hui (1.38%, as of Oct 21, 2026); EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.36%, as of Jul 31, 2026).
- When is the next earnings report from Kyungdong Pharm?
- Korean companies rarely announce results dates in advance. Based on when Kyungdong Pharm filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Kyungdong Pharm?
- Yes. The National Pension Service held 0.02% of Kyungdong Pharm shares as of Dec 31, 2021.
Company profile
The company, established in 1976, manufactures and sells pharmaceuticals and operates through three segments: pharmaceuticals, leasing, and other businesses. Its pharmaceutical segment accounts for about 95% of sales, with its main products including Duoloban tablets for circulatory system treatment and Alfotin soft capsules as a key merchandise item. Sales are made domestically to hospitals, clinics, pharmacies, and pharmaceutical companies, mainly through direct sales or drug wholesalers, and exports are handled through pharmaceutical trading companies, with exports making up roughly 1% of sales.
Written by AI from the company's latest annual report.
- Korean name
- 경동제약
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 류기성, 김경훈(각자 대표)
- Founded
- Feb 1976
- Listed
- Dec 1992
- Listed shares
- 30,768,766
- Fiscal year ends
- Month 12
- Website
- www.kdpharma.co.kr
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Insider shareholding reportOct 21, 2026
- Insider shareholding reportOct 8, 2026
- 5%+ holding reportAug 31, 2026
- Amended: Change of largest shareholderAug 27, 2026
- Insider shareholding reportAug 18, 2026
Titles in Korean until English translations are added.
Also known as: Kyungdong Pharm / 경동제약 / 011040 / KRX:011040
Source: KRX statistical information